UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DCD.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 orOR 15 (d) of ~~The Securities Exchange Act of 1934~~

~~Date~~The ofSecurities ~~Report~~Exchange ~~(Date~~Act of ~~earliest event reported): March 30, 2012 (October 10, 2011)~~1934

Date of Report (Date of earliest event reported) May 14, 2012 (May 9, 2012)

MEDICAL MAKEOVER CORPORATION OF AMERICA

(Exact name of registrant as specified in its charter)

Delaware	000-11596	020-~~30621~~0799349	~~65-0907798~~
(State or other jurisdiction of Incorporation or organization)		(Commission File Number)	(I.R.S. Employer Identification No.)
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

2101 Vista Parkway, Suite 292
West Palm Beach, Florida		33411
(Address of Principal Executive Office)		(Zip Code)

2101 Vista Pkwy., Ste. 292, West Palm Beach, FL 33411

(~~561~~Address of principal executive offices) ~~228-6148~~(Zip Code)

~~(Issuer~~Registrant's ~~Telephone~~telephone ~~Number~~number, including area code: (561) 228-6148

~~(Former name or former address, if changes since last report)~~N/A

~~The purpose~~(Former ofname ~~this current report~~or onformer ~~Form~~address, ~~8-K~~if ischanged tosince ~~report~~last ~~a change in the Company’s auditors~~report.)

~~ITEM 4.01 Changes in Registrant’s Certifying Accountant~~-----------------

OnCheck ~~October~~the ~~10,~~appropriate ~~2011,~~box ~~Malcolm~~below L.if ~~Pollard,~~the ~~Inc.~~Form ~~retired~~8-K ~~and~~filing ~~resigned~~is asintended to simultaneously satisfy the ~~Company’s~~filing ~~Independent~~obligation ~~Auditor~~of the registrant under any of the following provisions (see General Instruction A.2. below):

~~During the~~o ~~Registrant's~~Written ~~two most recent fiscal years and during any subsequent interim~~communications ~~period prior~~ pursuant to ~~the~~Rule ~~October~~425 ~~10,~~under ~~2011, resignation as~~ the ~~Company's~~ ~~independent auditors, there were~~Securities ~~no disagreements with~~Act ~~Malcolm L. Pollard, Inc., with respect to accounting or auditing issues of the type discussed in Item 304~~(~~a)(iv)~~17 CFR ~~of Regulation S-K~~230.425)

~~Malcolm~~o Soliciting material L.pursuant ~~Pollard,~~to ~~Inc.’s~~Rule ~~audit~~14a-12 ~~opinion~~under ~~for~~ the ~~last~~Exchange ~~two~~Act ~~years~~(17 ~~contained an audit scope modification due to the Company’s uncertainty regarding its ability to continue as a going concern~~CFR 240.14a-12)

~~On November 8, 2011,~~ o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange ~~Company~~Act ~~retained~~(17 ~~Hamilton,~~CFR ~~PC as the Company’s Independent Auditor~~240.14d-2(b))

~~During the Registrant's two most recent fiscal years or any subsequent~~o ~~interim period prior~~ Pre-commencement communications pursuant to ~~engaging Hamilton, PC,~~ Rule 13e-4(c) under the Exchange ~~Company,~~Act or(17 ~~someone~~CFR ~~on the Company's behalf, had not consulted Hamilton, PC regarding any of the accounting or auditing concerns stated in Item 304~~240.13e-4(aC)(2) ~~of Regulation S-K.~~

~~The~~SECTION ~~Company’s~~5 ~~Board~~– ofCORPORATE ~~Directors~~GOVERNANCE ~~approved~~AND ~~the change of auditors pursuant to Item 304(a)(1)(iii) of Regulation S-K.~~MANAGEMENT

OnItem ~~March 30, 2012, the Company provided Malcolm L~~5.02 ~~Pollard,~~Departure ~~Inc. with a copy~~ of ~~this~~Directors ~~disclosure~~or ~~and~~Principal ~~requested~~Officers; ~~that~~Election itof ~~furnish~~Directors; aAppointment ~~letter~~of toPrincipal ~~the Company, addressed to the SEC, stating that it agreed with the statements made herein or the reasons why it disagreed~~Officers.

EXHIBIT NUMBER		DESCRIPTION
Exhibit 16.1		Malcolm L. Pollard, Inc. letter regarding change of accountants

(b.) On May 11, 2012, Jason Smart resigned his positions as Chief Executive Officer, and Director of Medical Makeover Corporation of America (the “Company”). At the time of the resignation, there were no disagreements between Mr. Smart and the Company and the resignation was solely for personal reasons.

(d.) On May 9, 2012 one (1) new director was added pending the next annual meeting for the election of directors. Our sole existing director at that time, Jason Smart, nominated and appointed Ramon Pagan to serve as a Director until the next shareholder election of directors. Following acceptance of the directorship, Mr. Pagan was appointed Chief Financial Officer, President, and Chairman of the Board of Directors. Following this action, on May 11, 2012 Mr. Smart resigned as a Director as outlined in (a.) and (b.) above, effective immediately.

Mr. Pagan, age 35, has educational and practical experience in bookkeeping and accounting related matters. He has studied accounting at Florida Atlantic University and is pursuing becoming a Certified Public Accountant (CPA). Prior to accepting this position, he served as a Principal and Sole Officer and Director of National Business Investors, Inc., a lender to the Company. He has held other positions for various periods of time in the private sector doing internal auditing and related activities. In February 2009 he became the Sole Principal of Ponce De Leon Consulting Group, Inc. and continued his accounting related work on behalf of that entity.

SIGNATURES

InPursuant ~~accordance~~to ~~with Section 13~~ the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, ~~thereunto~~hereunto duly authorized.

Medical Makeover Corporation of America

	MEDICAL MAKEOVER CORPORATION OF AMERICA

May 14, 2012	By:	/s/ Ramon Pagan
		Name: Ramon Pagan
		Title: President

(Registrant)

By: /s/ Jason Smart

Jason Smart, President and Chairman of the Board

Date: March 30, 2012

Filing Compare · MEDICAL MAKEOVER CORP OF AMERICA